Featured Articles

31. Accelerating AI Innovation In Pharma: Collaboration Vs. Competition 3/12/2024

    Here we delve into the debate, informed by insights from panel discussions at SCOPE 2024 on generative AI in clinical research, focusing on technology and data challenges.

32. What FDA, EMA Discussion Papers Reveal About AI In Clinical Research 12/18/2023

    Learn how having a comprehensive understanding of regulatory perspectives on AI ethics will prove invaluable for researchers evaluating the integration of AI technology into their trials.

33. 10 FAQs On eConsent 11/16/2023

    Closely examine the challenges of adoption, integration, and compliance measures involving eConsent and gain valuable insights for those contemplating their incorporation in clinical trials.

34. Preparing For Post-Market Clinical Follow-Up Under EU MDR 9/15/2023

    Gain a better understanding of the primary challenges faced by the life sciences industry's commercial model in response to the updated EU MDR guidelines.

35. Impact Of Direct Data Capture On Clinical Trial Timelines 9/15/2023

    Explore a broader strategy for shortening clinical trial timelines that encompasses various elements, ranging from enhancing interoperability to implementing AI-driven technologies.

36. Essity Uses eConsent To Optimize Enrollment 8/15/2023

    See how a global hygiene and health company was able to deploy virtual methods through a strategic partnership to recruit and retain participants, streamline consent, and analyze patient data.

37. Biomarkers And Digital Endpoints For Modern Trials 8/15/2023

    Explore how biomarkers and digital endpoints address inefficiencies, significantly accelerating the pace of clinical trial processes, and have the potential to revolutionize medical research.

38. How Electronic Source Data Revolutionizes Clinical Research 7/14/2023

    By increasing interoperability and embracing digital solutions, see how the research community can maximize the benefits offered by eSource, leading to improved trial outcomes and data quality.

39. The State Of Design And Evidence Generation In Rare Disease Trials 7/14/2023

    Discover how innovative trial designs, the utilization of RWD and RWE, and the development of synthetic control arms are poised to drive advancements in the field of rare diseases.

40. How Master Protocols Are Accommodating Trial Advances 6/7/2023

    As a result of trial design changes in the life sciences industry, learn what drug developers are doing to keep pace with the ongoing advancements in genomics, immunology, and precision medicine.